£1.5 million placing supporting growth of ACCRUFeR

AI SummaryClose X

Shield Therapeutics PLC announced the completion of a placing to raise gross proceeds of £1.5 million through the issue of 20,000,000 new ordinary shares at a price of 7.5 pence per share. The issue price represents a premium of approximately 5% to the 30-day VWAP of 7.13 pence per existing ordinary share up to September 12, 2025. The placing shares represent approximately 1.9% of the existing issued ordinary share capital. Admission to trading on AIM is expected on September 19, 2025, following which the total number of ordinary shares in issue will be 1,061,690,484.

Disclaimer*

UK 100

Latest directors dealings